Global Stock News

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business – GenomeWeb

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business – GenomeWeb

NEW YORK Quidel said on Monday that it and Beckman Coulter have reached a settlement of a legal dispute over the Triage B-type naturietic peptide, or BNP, assay business.
As part of the settlement, Quidel will supply reagents for the assay while transitioning…

Click here to view the original article.

Share this article

Scroll to Top